| Date | Time | Source | Headline | Symbol | Company |
| 01/10/2008 | 1:20PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/07/2008 | 8:35AM | PR Newswire (US) | SYMLIN Pen-Injector Devices Now Available | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/03/2008 | 6:11PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/03/2008 | 6:09PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/02/2008 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/02/2008 | 12:28PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/26/2007 | 1:53PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/21/2007 | 4:51PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/21/2007 | 11:50AM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/19/2007 | 12:04PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/18/2007 | 5:21PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/14/2007 | 12:53PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Prospectus filed pursuant to Rule 424(b)(3) (424B3) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/12/2007 | 2:46PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/12/2007 | 2:44PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/12/2007 | 2:42PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/07/2007 | 5:12PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/06/2007 | 6:00AM | PR Newswire (US) | Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/05/2007 | 6:50PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/30/2007 | 7:00AM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/27/2007 | 4:15PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/21/2007 | 7:00AM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Research & Development Day | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/20/2007 | 6:51PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/20/2007 | 2:39PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/19/2007 | 11:12AM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/15/2007 | 5:12PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/15/2007 | 4:06PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/15/2007 | 7:00AM | PR Newswire (US) | Pramlintide and Leptin Combination Treatment Demonstrates 12.7 Percent Weight Loss in 24-Week Clinical Obesity Study | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/13/2007 | 3:10PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc (Other) (424B3) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/13/2007 | 1:51PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc (Other) (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/06/2007 | 4:07PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Quarterly Report (10-Q) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |